Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
heparinoid + hyaluronidase
- Development stage
- Unknown
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
Heparinoid + hyaluronidase is a topical combination drug used primarily for the treatment of soft tissue injuries, bruising, swelling, and pain associated with trauma such as fractures or sprains. Heparinoids are glycosaminoglycan derivatives with anticoagulant and anti-inflammatory properties that help reduce swelling and improve local blood circulation. Hyaluronidase is an enzyme that breaks down hyaluronic acid in connective tissue, increasing tissue permeability and promoting the absorption of other drugs or fluids at the site of application. Together, this combination enhances local blood flow, reduces edema (swelling), relieves pain, and accelerates healing by facilitating the dispersion of accumulated fluids in injured tissues.
- Other names
- 消定膏
02
Targets
ATIII (Antithrombin III)
Beyond the preview
Go deeper on heparinoid + hyaluronidase.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on heparinoid + hyaluronidase.